Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Eclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory Anticipation

Published 09/04/2024, 20:32
Updated 09/04/2024, 21:40
© Reuters.  Eclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory Anticipation

Benzinga - by Patricio Liddle, .

In the latest report from Water Tower Research (WTR) published Monday, seasoned industry analyst Jesse Redmond provides a comprehensive overview of the most recent investment trends and legal shifts in the cannabis sector.

Redmond’s analysis will doubtless trigger conversation at the upcoming Benzinga Cannabis Capital Conference in Florida on April 16-17, where he will be a featured speaker, unveiling the future of cannabis investments and policy reform.

A Week Marked By ETF Volatility The cannabis industry witnessed notable fluctuations the past week, with the US-based AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) seeing a modest gain of 1.10%, contrasting sharply with the global AdvisorShares Pure Cannabis ETF (NYSE:YOLO) leap of 3.92%, as noted in WTR's report. This surge underscores a pivotal moment, primarily fueled by Canadian entities, marking a remarkable year-to-date uptrend of 49.70% for MSOS and 39.47% for YOLO.

AYR Wellness Leads With Strategic Catalysts Looking back at last week’s triumphs, Redmond spotlights AYR Wellness (OTCQX:AYRWF) as a front-runner, boasting an 8.47% increase. CEO David Goubert’s discussion on Water Tower Research's podcast “Higher Exchanges” shed light on promising catalysts for 2024. With 80% of AYR’s operations in the medical sector, the company stands on the brink of expansion, particularly in states poised for adult-use transitions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Florida’s Pivotal Role in Cannabis Expansion Furthermore, Redmond's analysis addressed the pivotal Florida Supreme Court ruling permitting Amendment 3 on the fall ballot. This decision could potentially double the Sunshine State’s $2 billion medical cannabis market. With 135 million tourists last year, Florida’s transition to adult-use cannabis could catalyze significant sales, especially as neighboring states lack similar programs. Trulieve (OTCQX:TCNNF) leads the charge with a robust retail and cultivation footprint, essential in a market without wholesale trading.

CLS Holdings Ventures Into New York Also, CLS Holdings (OTCQB:CLSH)‘ strategic move to introduce City Trees in New York’s recreational cannabis market heralds a significant expansion. Moreover, with BDSA forecasting a $1.3 billion market in 2024, CLS’s asset-light approach and partnership with Basix Mixtures spotlight a savvy entrance into one of the world’s most promising cannabis markets.

Industry On The Brink Of DEA Rescheduling? Closing the report on a note of hope, Redmond delves into the growing speculation as the industry approaches the 4/20 holiday, with Senator Cory Booker hinting at possible DEA action. With the upcoming election and cannabis policies taking center stage, Redmond’s insights underscore a crucial period of historic potential for the cannabis industry.

Don’t miss the opportunity to hear Jesse Redmond, a leading voice in cannabis research. The Benzinga Cannabis Capital Conference is returning to Florida at a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.